Who Owns Cytosorbents Stock?
NASDAQ: CTSOHealthcareMedical DevicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 25.53%
- Held by insiders
- 16.25%
- Institutional holders
- 55
- Institutions 25.5%
- Insiders 16.3%
- Public and other 58.2%
Who owns Cytosorbents stock?
Institutional investors own about 25.5% of Cytosorbents's shares, spread across 55 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 16.25% of CTSO.
The largest institutional holders are Avenir Corp (8.23%), Neuberger Berman Group, LLC (3.12%) and Vanguard Capital Management LLC (3.04%). Together, the top 10 institutions control 22.8% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their CTSO positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CTSO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Avenir Corp | 259.46K | 8.23% | -0.5% |
| Neuberger Berman Group, LLC | 98.44K | 3.12% | +17.0% |
| Vanguard Capital Management LLC | 95.70K | 3.04% | +1.8% |
| CM Management, LLC | 73.83K | 2.34% | 0.0% |
| Skylands Capital, LLC | 60.57K | 1.92% | -29.1% |
| Blackrock Inc. | 31.36K | 1.00% | -19.9% |
| Geode Capital Management, LLC | 30.10K | 0.96% | -14.9% |
| Sargent Investment Group, LLC | 27.79K | 0.88% | +1.1% |
| Pathstone Holdings, LLC | 25.00K | 0.79% | -0.0% |
| Vanguard Fiduciary Trust Co | 15.81K | 0.50% | +0.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CTSO
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 63.72K | 2.02% |
| NEUBERGER BERMAN EQUITY FUNDS-Neuberger Intrinsic Value Fund | 32.33K | 1.03% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 28.72K | 0.91% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 14.61K | 0.46% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 4.72K | 0.15% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 3.93K | 0.12% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 1.78K | 0.06% |
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | 1.48K | 0.05% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 1.11K | 0.04% |
| MORGAN STANLEY PATHWAY Fd.S-Morgan Stanley Pathway Small-Mid Cap Eqy. | 1.09K | 0.03% |
Frequently asked questions
Who is the largest shareholder of Cytosorbents?
Avenir Corp is the largest institutional shareholder of CTSO, owning 8.23% of shares outstanding (259.46K shares) as of its latest 13F filing.
What percentage of Cytosorbents is owned by institutions?
Institutions own about 25.5% of CTSO shares and 30.5% of the public float.
How much of Cytosorbents do insiders own?
Insiders, such as officers and directors, own about 16.25% of CTSO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.